World's Best Scientists 2026 revealed!
Award Badge
Microbiology
USA
2026

D-Index & Metrics

Microbiology

D-Index
143
Citations
79936
World Ranking
44
National Ranking
22

Research.com Recognitions

  • 2026 - Research.com Microbiology in United States Leader Award
  • 2025 - Research.com Microbiology in United States Leader Award
  • 1999 - Fellow of the American Academy of Microbiology Microbial Ecology
  • 1948 - Fellow of the Royal Society of Canada

Overview

Ronald N. Jones is affiliated with JMI Laboratories in the United States. Their research primarily focuses on the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Within these areas, Jones has contributed to subfields such as Molecular Medicine, Epidemiology, Pharmacology, Applied Microbiology and Biotechnology, and Clinical Biochemistry.

Their work addresses several main topics including Antibiotic Resistance in Bacteria, Antibiotics Pharmacokinetics and Efficacy, Antibiotic Use and Resistance, Bacterial Identification and Susceptibility Testing, Global Maternal and Child Health, Pneumonia and Respiratory Infections, and Analytical Methods in Pharmaceuticals.

Jones has published research in various scientific venues. These include:

  • The Lancet Regional Health - Americas
  • Antimicrobial Agents and Chemotherapy
  • Open Forum Infectious Diseases
  • European Journal of Drug Metabolism and Pharmacokinetics
  • Diagnostic Microbiology and Infectious Disease

Some of their recently published papers are:

  • The burden of antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis, 2023, The Lancet Regional Health - Americas
  • Activity of Plazomicin Tested against Enterobacterales Isolates Collected from U.S. Hospitals in 2016-2017: Effect of Different Breakpoint Criteria on Susceptibility Rates among Aminoglycosides, 2020, Antimicrobial Agents and Chemotherapy
  • Old In Vitro Antimicrobial Breakpoints Are Misleading Stewardship Efforts, Delaying Adoption of Innovative Therapies, and Harming Patients, 2020, Open Forum Infectious Diseases
  • Pharmacokinetics and Pharmacodynamics of High-Dose Piperacillin-Tazobactam in Obese Patients, 2021, European Journal of Drug Metabolism and Pharmacokinetics
  • Reanalysis of cefazolin surrogate susceptibility breakpoints utilized as guidances for oral cephalosporin treatments of uncomplicated urinary tract infections: caution concerning application to cefadroxil, 2020, Diagnostic Microbiology and Infectious Disease

Frequent coauthors collaborating with Jones include:

  • Rodrigo E. Mendes
  • Gisela Robles Aguilar
  • Lucien Swetschinski
  • Nicole Davis Weaver
  • Kevin S Ikuta

Jones has received recognition through awards such as:

  • Fellow of the American Academy of Microbiology, 1999, Microbial Ecology
  • Fellow of the Royal Society of Canada, 1948

Best Publications

  • Nosocomial Bloodstream Infections in United States Hospitals: A Three-Year Analysis

    Michael B. Edmond;Sarah E. Wallace;Donna K. McClish;Michael A. Pfaller

  • Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data

    Ian Phillips;Mark Casewell;Tony Cox;Brad De Groot

  • Microbial Etiologies of Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

    Ronald N. Jones

  • 10 × '20 Progress—Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America

    Helen W. Boucher;George H. Talbot;Daniel K. Benjamin;Daniel K. Benjamin;John Bradley;John Bradley

  • Bacterial Pathogens Isolated from Patients with Bloodstream Infection: Frequencies of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)

    Michael A. Pfaller;Ronald N. Jones;Gary V. Doern;Kari Kugler

  • Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997-2016.

    Michael A Pfaller;Daniel J Diekema;John D Turnidge;Mariana Castanheira

  • National Surveillance of Nosocomial Blood Stream Infection Due to Species of Candida Other than Candida albicans: Frequency of Occurrence and Antifungal Susceptibility in the SCOPE Program

    Michael A Pfaller;Ronald N Jones;Shawn A Messer;Michael B Edmond

  • Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997–2002)

    Douglas J. Biedenbach;Gary J. Moet;Ronald N. Jones

  • The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program

    Daniel J. Diekema;Po Ren Hsueh;Rodrigo E. Mendes;Michael A. Pfaller

  • Resistance Patterns Among Nosocomial Pathogens: Trends Over the Past Few Years

    Ronald N. Jones

  • Prevalence of Antimicrobial Resistance Among Respiratory Tract Isolates of Streptococcus pneumoniae in North America: 1997 Results from the SENTRY Antimicrobial Surveillance Program

    Gary V. Doern;Michael A. Pfaller;Kari Kugler;Juliana Freeman

  • Molecular characterization of SPM-1, a novel metallo-β-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme

    Mark A. Toleman;Alan M. Simm;Tanya A. Murphy;Ana C. Gales

  • Molecular characterization of a beta-lactamase gene, blaGIM-1, encoding a new subclass of metallo-beta-lactamase.

    Mariana Castanheira;Mark A. Toleman;Ronald N. Jones;Franz J. Schmidt

  • Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004)

    Gary J. Moet;Ronald N. Jones;Douglas J. Biedenbach;Matthew G. Stilwell

  • Contemporary Assessment of Antimicrobial Susceptibility Testing Methods for Polymyxin B and Colistin: Review of Available Interpretative Criteria and Quality Control Guidelines

    Ana C. Gales;Ana C. Gales;Adriana O. Reis;Ronald N. Jones

  • Efficient Detection and Long-Term Persistence of the Carriage of Methicillin-Resistant Staphylococcus aureus

    Melissa D. Sanford;Andreas F. Widmer;Martha J. Bale;Ronald N. Jones

  • Early Dissemination of NDM-1- and OXA-181-Producing Enterobacteriaceae in Indian Hospitals: Report from the SENTRY Antimicrobial Surveillance Program, 2006-2007

    Mariana Castanheira;Lalitagauri M. Deshpande;Dilip Mathai;Jan M. Bell

  • Bloodstream Infections Due to Candida Species: SENTRY Antimicrobial Surveillance Program in North America and Latin America, 1997-1998

    Pfaller;R N Jones;G V Doern;H S Sader

  • Characterization of Pseudomonas aeruginosa Isolates: Occurrence Rates, Antimicrobial Susceptibility Patterns, and Molecular Typing in the Global SENTRY Antimicrobial Surveillance Program, 1997–1999

    A. C. Gales;R. N. Jones;J. Turnidge;R. Rennie

  • Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program

    Lalitagauri M. Deshpande;Thomas R. Fritsche;Gary J. Moet;Douglas J. Biedenbach

  • Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010).

    Ana C. Gales;Mariana Castanheira;Ronald N. Jones;Hélio S. Sader

Frequent Co-Authors

Helio S. Sader
Helio S. Sader JMI Laboratories
Michael A. Pfaller
Michael A. Pfaller JMI Laboratories
Rodrigo E. Mendes
Rodrigo E. Mendes JMI Laboratories
Robert K. Flamm
Robert K. Flamm JMI Laboratories
Mariana Castanheira
Mariana Castanheira JMI Laboratories
Thomas R. Fritsche
Thomas R. Fritsche Marshfield Clinic
David J. Farrell
David J. Farrell University Hospital Southampton NHS Foundation Trust
Paul R. Rhomberg
Paul R. Rhomberg University of Iowa
Arthur L. Barry
Arthur L. Barry University of California, Davis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology opens doors to diverse career opportunities in healthcare and research. For those interested in healthcare management, exploring a health information management salary offers insights into rewarding roles that combine biology knowledge with data management.

Many students prefer pursuing the best cahiim accredited him programs online for quality education that meets industry standards. Such programs prepare graduates for vital administrative roles that support clinical and laboratory settings.

For quicker entry into the field, certificate options like the quickest medical billing and coding certificate online provide a fast-track to specialized healthcare documentation roles that complement microbiology expertise.

Additionally, exploring online healthcare programs broadens prospects, offering flexible paths to medical degrees that align with microbiology, such as public health or clinical laboratory sciences. These pathways ensure diverse career options in both research and healthcare industries.

Best Scientists Citing Ronald N. Jones

Trending Scientists